Zacks Research upgraded shares of Synopsys (NASDAQ:SNPS – Free Report) from a strong sell rating to a hold rating in a report issued on Monday morning,Zacks.com reports.
Other research analysts have also issued reports about the stock. Rosenblatt Securities reaffirmed a “neutral” rating and set a $605.00 price objective (down from $650.00) on shares of Synopsys in a research note on Wednesday, September 10th. Morgan Stanley decreased their price objective on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a research note on Thursday, September 11th. Baird R W cut Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Mizuho dropped their price objective on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Finally, Bank of America reaffirmed an “underperform” rating and issued a $525.00 price objective (down previously from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, Synopsys has a consensus rating of “Hold” and an average target price of $562.14.
Get Our Latest Analysis on SNPS
Synopsys Trading Up 0.0%
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Equities research analysts predict that Synopsys will post 10.64 EPS for the current fiscal year.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the transaction, the chief executive officer owned 71,615 shares in the company, valued at $42,181,951.15. This trade represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at $10,278,468. This trade represents a 32.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 in the last quarter. 0.62% of the stock is currently owned by company insiders.
Institutional Trading of Synopsys
Several institutional investors have recently modified their holdings of SNPS. Saudi Central Bank purchased a new position in Synopsys in the 1st quarter worth approximately $26,000. Alpine Bank Wealth Management increased its position in shares of Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. lifted its stake in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares in the last quarter. Millstone Evans Group LLC purchased a new stake in Synopsys during the third quarter worth about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 53 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Basic Materials Stocks Investing
- Occidental Petroleum is a Buy in Q4 2025
- Investing In Preferred Stock vs. Common Stock
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- What is MarketRank™? How to Use it
- Amazon Is One of the Clearest Buys If the Market Dips Again
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
